No Cover Image

Journal article 1920 views 518 downloads

Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?

Alwena Morgan Orcid Logo, Daniel J. Rees, Zane B. Andrews, Jeffrey S. Davies

Neuropharmacology, Volume: 136, Pages: 317 - 326

Swansea University Author: Alwena Morgan Orcid Logo

  • MorganAlwena.pdf

    PDF | Accepted Manuscript

    Released under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND).

    Download (1.15MB)

Check full text

DOI (Published version): 10.1016/j.neuropharm.2017.12.027

Published in: Neuropharmacology
ISSN: 00283908
Published: 2018
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa37949
first_indexed 2018-01-05T14:28:33Z
last_indexed 2018-12-14T19:48:54Z
id cronfa37949
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2018-12-14T15:35:18.1375825</datestamp><bib-version>v2</bib-version><id>37949</id><entry>2018-01-05</entry><title>Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?</title><swanseaauthors><author><sid>9ea39c3d0935c897cb9fcd3ba550af71</sid><ORCID>0000-0002-3441-5357</ORCID><firstname>Alwena</firstname><surname>Morgan</surname><name>Alwena Morgan</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2018-01-05</date><deptcode>MEDS</deptcode><abstract/><type>Journal Article</type><journal>Neuropharmacology</journal><volume>136</volume><paginationStart>317</paginationStart><paginationEnd>326</paginationEnd><publisher/><issnPrint>00283908</issnPrint><keywords>Parkinson&amp;apos;s disease; Ghrelin; Dementia</keywords><publishedDay>1</publishedDay><publishedMonth>7</publishedMonth><publishedYear>2018</publishedYear><publishedDate>2018-07-01</publishedDate><doi>10.1016/j.neuropharm.2017.12.027</doi><url/><notes/><college>COLLEGE NANME</college><department>Medical School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>MEDS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2018-12-14T15:35:18.1375825</lastEdited><Created>2018-01-05T11:56:27.5884055</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Alwena</firstname><surname>Morgan</surname><orcid>0000-0002-3441-5357</orcid><order>1</order></author><author><firstname>Daniel J.</firstname><surname>Rees</surname><order>2</order></author><author><firstname>Zane B.</firstname><surname>Andrews</surname><order>3</order></author><author><firstname>Jeffrey S.</firstname><surname>Davies</surname><order>4</order></author></authors><documents><document><filename>0037949-05012018115914.pdf</filename><originalFilename>MorganAlwena.pdf</originalFilename><uploaded>2018-01-05T11:59:14.4030000</uploaded><type>Output</type><contentLength>1181763</contentLength><contentType>application/pdf</contentType><version>Accepted Manuscript</version><cronfaStatus>true</cronfaStatus><embargoDate>2018-12-23T00:00:00.0000000</embargoDate><documentNotes>Released under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND).</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language></document></documents><OutputDurs/></rfc1807>
spelling 2018-12-14T15:35:18.1375825 v2 37949 2018-01-05 Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease? 9ea39c3d0935c897cb9fcd3ba550af71 0000-0002-3441-5357 Alwena Morgan Alwena Morgan true false 2018-01-05 MEDS Journal Article Neuropharmacology 136 317 326 00283908 Parkinson&apos;s disease; Ghrelin; Dementia 1 7 2018 2018-07-01 10.1016/j.neuropharm.2017.12.027 COLLEGE NANME Medical School COLLEGE CODE MEDS Swansea University 2018-12-14T15:35:18.1375825 2018-01-05T11:56:27.5884055 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Alwena Morgan 0000-0002-3441-5357 1 Daniel J. Rees 2 Zane B. Andrews 3 Jeffrey S. Davies 4 0037949-05012018115914.pdf MorganAlwena.pdf 2018-01-05T11:59:14.4030000 Output 1181763 application/pdf Accepted Manuscript true 2018-12-23T00:00:00.0000000 Released under a Creative Commons Attribution Non-Commercial No Derivatives License (CC-BY-NC-ND). true eng
title Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
spellingShingle Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
Alwena Morgan
title_short Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
title_full Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
title_fullStr Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
title_full_unstemmed Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
title_sort Ghrelin mediated neuroprotection - A possible therapy for Parkinson's disease?
author_id_str_mv 9ea39c3d0935c897cb9fcd3ba550af71
author_id_fullname_str_mv 9ea39c3d0935c897cb9fcd3ba550af71_***_Alwena Morgan
author Alwena Morgan
author2 Alwena Morgan
Daniel J. Rees
Zane B. Andrews
Jeffrey S. Davies
format Journal article
container_title Neuropharmacology
container_volume 136
container_start_page 317
publishDate 2018
institution Swansea University
issn 00283908
doi_str_mv 10.1016/j.neuropharm.2017.12.027
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 1
active_str 0
published_date 2018-07-01T04:16:57Z
_version_ 1851093384332050432
score 11.089386

Similar Items